Aayush Agrawal, promoter of Ajanta Pharma Limited, has created a pledge on 11,11,111 shares for a new loan. This action is disclosed as per SEBI (SAST) Regulations, 2011. The pledge, created on 10-Jun-26, impacts the shareholding of Aayush M Agrawal, trustee Aayush Agrawal Trust, with RBL Bank Ltd as the beneficiary for a new loan. Details of the encumbrance have been filed with the stock exchanges and the company.
Promoter Encumbers Shares for New Loan
Aayush Agrawal, acting as the trustee for the Aayush Agrawal Trust and a promoter of Ajanta Pharma Limited, has formally announced the creation of a pledge on a significant portion of his shareholding. The disclosure, made in accordance with the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, details the encumbrance of 11,11,111 shares. The stated reason for this action is to secure a new loan.
Detailed Disclosure of Pledge
The encumbrance was officially created on 10-Jun-26, with the pledge specifically benefiting RBL Bank Ltd. This move relates to the shares held by Aayush M Agrawal, trustee Aayush Agrawal Trust. The post-event holding of encumbered shares for this entity shows an increase, reflecting the newly pledged amount. The total number of shares encumbered is 1,14,45,087, representing 9.16% of the total share capital, with a specific loan amount associated with 8,92,860 shares (0.71% of capital) and another for 2,18,251 shares (0.17% of capital).
Regulatory Compliance and Notifications
Ajanta Pharma Limited has been notified of this development. The disclosure also includes information on other promoters and their respective shareholdings and encumbrances, such as Yogesh M Agrawal, trustee Yogesh Agrawal Trust, who has 27,70,000 shares encumbered (2.22% of capital), and Ravi P Agrawal, trustee Ravi Agrawal Trust, with 57,56,777 shares encumbered (4.61% of capital).
The announcement confirms that the prescribed forms under Regulation 31(1) & 31(2) of the SEBI (SAST) Regulations, 2011, providing comprehensive details of this pledge creation, have been submitted. The stock exchanges (BSE & NSE) and the target company have been duly informed, and their acknowledgement of the receipt of this information has been requested.
Source: BSE
